No authors listed. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet. 1986;2:57–66.
No authors listed. The Studies of Left Ventricular Dysfunction (SOLVD): Limited Access Database. Version 2.0. Available from URL: https://biolincc.nhlbi.nih.gov/static/studies/solvd/LAD_Overview.pdf (accessed 25 June 2012).
Pais P, Pogue J, Gerstein H, Zachariah E, Savitha D, Jayprakash S, Nayak PR, Yusuf S. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet. 1996;348:358–63.
INTER-HEART: A Global Case-Control Study of Risk Factors for Acute Myocardial Infarction. Available from URL: http://www.phri.ca/interheart/ (accessed 25 June 2012).
INTERSTROKE: A Study of the Importance of Conventional and Emerging Risk Factors of Stroke in Different Regions and Ethnic Groups of the World. Available from URL: http://www.phri.ca/body.cfm?id=235 (accessed 25 June 2012).
Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal infuences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158:1–7.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145–53.
Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154–60